Top institutional shareholders include Caxton Corp (4.86%). The Aden Forecast. Not ready to subscribe just yet? Addex Therapeutics Ltd () Stock Market info Recommendations: Buy or sell Addex Therapeutics stock? MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Thinking about buying or selling stock in ADXN? Addex Therapeutics Ltd American Depositary Shares (ADXN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Addex shares trade on the SIX Swiss Exchange main board under the stock symbol ADXN (ISIN: CH0029850754). Get short term trading ideas from the MarketBeat Idea Engine. Based on an average daily volume of 114,100 shares, the short-interest ratio is presently 0.1 days. As of February 12th, there was short interest totaling 4,200 shares, a drop of 67.9% from the January 28th total of 13,100 shares. St. Louis, MO 63179-9927. During the day the stock fluctuated 5.59% from a day low at 1.70 Fr to a day high of 1.80 Fr. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. See what's happening in the market right now with MarketBeat's real-time news feed. Addex Therapeutics' mailing address is CHEMIN DES AULX 12 PLAN-LES-OUATES, GENEVA V8, CH-1228. See ADDEX N (ADXN.SW) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. View the latest market news and prices, and trading information. Get Our PREMIUM Forecast Now, from ONLY $7.49! View which stocks have been most impacted by COVID-19. Fundamental company data provided by Zacks Investment Research. In the Green. Addex Therapeutics saw a drop in short interest in the month of February. Stock Market Forecast: I Know First S&P 500 & Nasdaq Evaluation Report – Accuracy Up To 72%; Top S&P 500 Stocks Performance Report By Day Of The Week By I Know First Evaluation; MU Stock Forecast: I Know First Stock Forecasts Evaluation Report; Nvidia Stock Predictions: I Know First Stock Forecasts Evaluation Report Get a free ADXN technical analysis report to make a better ADXN stock predictions on how the stock will perform in the near future. Addex Therapeutics saw a increase in short interest during the month of February. In the medium term (3months), ADXS's stock price should outperform the market by 7.31%. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. As of February 26th, there was short interest totaling 6,600 shares, an increase of 57.1% from the February 11th total of 4,200 shares. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland. Addex Therapeutics Ltd (ADXN:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Disclaimer. View real-time stock prices and stock quotes for a full financial overview. Based on aggregate information from My MarketBeat watchlists, some companies that other Addex Therapeutics investors own include Achillion Pharmaceuticals (ACHN), Aurora Cannabis (ACB), ACADIA Pharmaceuticals (ACAD), Arbutus Biopharma (ABUS), Abacus Property Group (ABP), Advanced Biomedical Technologies (ABMT), Abiomed (ABMD), ARCA biopharma (ABIO), Abeona Therapeutics (ABEO) and Abcam (ABCZY). Addex Therapeutics Ltd - ADR NASDAQ Updated Mar 11, 2021 12:36 AM. (Add your “outperform” vote. Stock screener for investors and traders, financial visualizations. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Who are Advaxis' key executives? Factset: FactSet Research Systems Inc.2019. P.O.Box 790260. Export data to Excel for your own analysis. Analyzing The Downward Movement in Addex Therapeutics's Stock Today, Addex Announces Filing of Registration Statement for Proposed Public Offering of Securities, Addex Reports Q3 2020 Financial Results and Provides Corporate Update, ADDEX THERAPEUTICS TO RELEASE Q3 2020 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON NOVEMBER 3rd, 2020, Addex to Present at the Investora Conference, Van Leeuwenhoeck Issues Updated Addex Equity Research Report, Receive Analysts' Upgrades and Downgrades Daily. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. View today's stock price, news and analysis for Addex Therapeutics Ltd. (ADXN). Please log in to your account or sign up in order to add this asset to your watchlist. View our earnings forecast for Addex Therapeutics. Our Accessibility Statement Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Some companies that are related to Addex Therapeutics include Theratechnologies (THERF), Abeona Therapeutics (ABEO), Osmotica Pharmaceuticals (OSMT), Onconova Therapeutics (ONTX), Genprex (GNPX), Enlivex Therapeutics (ENLV), Mustang Bio (MBIO), Milestone Pharmaceuticals (MIST), vTv Therapeutics (VTVT), ObsEva (OBSV), Exicure (XCUR), Metacrine (MTCR), Harrow Health (HROW), Medicenna Therapeutics (MDNA) and Aptinyx (APTX). View Addex Therapeutics' Short Interest. 1. Addex Therapeutics has a market capitalization of $59.02 million and generates $2.78 million in revenue each year. ADXN Buy or Sell? In the past three months, Addex Therapeutics insiders have not sold or bought any company stock. Stock analysis for Addex Therapeutics Ltd (ADXN:SIX Swiss Ex) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ADXN | A complete ADXN overview by MarketWatch. Find real-time ADXN - Addex Therapeutics Ltd stock quotes, company profile, news and forecasts from CNN Business. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Learn more. Sign up for free to our mailing list and receive news and updates. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. ADXS stock forecast Our latest prediction for Advaxis, Inc.'s stock price was made on the Feb. 2, 2018 when the stock price was at 2.90$.. Close price at the end of the last trading day (Wednesday, 3rd Mar 2021) of the ADXN.SW stock was 1.76 Fr. MarketBeat just released five new trading ideas, but Addex Therapeutics wasn't one of them. The official website for Addex Therapeutics is www.addextherapeutics.com. Find market predictions, ADXN financials and market news. View all of ADXN's competitors. Date Range. Investors can use this forecasting interface to forecast Addex Therapeutics historical stock prices and determine the direction of Addex Therapeutics's future trends based on various well-known forecasting models. Want to see which stocks are moving? The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. ), Addex Therapeutics has received 0 “underperform” votes. Addex Therapeutics' stock is owned by many different institutional and retail investors. The ADXN stock forecast is provided by MarketClub with their Trade Triangle system.. ADXN Stock … CNN Sans™ & © 2016 Cable News Network. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. ADXN -- USA Stock : USD 11.76 0.37 3.25% : Addex Therapeutics Stock Forecast is based on your current time horizon. There is not enough analysis data for Addex Therapeutics. A Warner Media Company. Since then, ADXS stock has increased by 20.0% and is now trading at $0.80. Learn more. Post-Market 0.61 (5.51%) Addex Therapeutics trades on the NASDAQ under the ticker symbol "ADXN.". It has license and collaboration agreement with Janssen Pharmaceuticals Inc. to develop mGluR2PAM compounds for the treatment of human health. Only 0.34% of the stock of Addex Therapeutics is held by institutions. Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. © 2020 Cable News Network. Learn about financial terms, types of investments, trading strategies and more. AC Investment Inc. delivers machine learning based share price forecast. Addex Therapeutics' management team includes the following people: Start Your Risk-Free Trial Subscription Here, Editor of top German newspaper suspended in compliance probe, Timing key in consulting deal between FirstEnergy, regulator, You Must Recognize Your Own Achievements First Before Expecting Others To, The Latest: Paris may face new lockdown as ICUs fill up, 'Big burden' for schools trying to give kids internet access, The Latest: Pakistan imposes partial lockdown in some areas, Three Mall Retailers For Your Reopening Watchlist, 3 Growth Stocks with Above Market Dividend Yields, 3 Best Stocks to Buy That You’ve Probably Never Heard Of, Ferroglobe Will Get a Big Lift From Demand For Silcon Wafers, Blue Bird Stock is a Dual Tailwinds EV and Re-Opening Play, Nautilus Stock is a Pullback Buying Opportunity Here, The Launch of Truforma Should Send Zomedica to An All-Time High, Defi Markets Pause But New Highs Are In Sight, 7 Stocks That Cathie Wood is Buying And You Should Too, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, Addex Therapeutics Limited (ADXN) CEO Tim Dyer on Q4 2020 Results - Earnings Call Transcript, Addex Therapeutics to Release Full-Year 2020 Financial Results and Host Conference Call on March 11, 2021, Addex to Present at the H.C. Wainwright Global Life Sciences Conference, Enamine Extend Collaboration With Prominent Swiss Biotech, Addex Provides Trading Update and Completes 2020 with Strong Cash Position of CHF18.7 million, Addex GABAB Positive Allosteric Modulator Demonstrates Promise in Alcohol Use Disorder, Stock Alert: Addex Therapeutics Soars 40%, The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping, Addex ADX71149 Receives IND Approval to Start a Phase 2a Clinical Study in Epilepsy, Addex Successfully Completes $11.5 Million Capital Increase Including Full Exercise of Underwriter's Option to Purchase Additional Securities, Addex to Present at the Baader Helvea Swiss Equities Conference, Addex Successfully Completes $11.5 Million Capital Increase Including Full Exercise of Underwriter’s Option to Purchase Additional Securities, Addex Announces Pricing of $10.0 Million Global Offering, Why Is It Moving? Most stock quote data provided by BATS. ADDEX N (ADXN.SW) stock forecast and price target. Bollinger Bands charts for ADXN.SW (Addex Therapeutics Ltd). (RTTNews) - What's moving these stocks in pre-market hours today? The current stock price of Addex Therapeutics Ltd is $12.30; ADXN stock price opened the day at $12.5 after previous close of $11.52; During the day, Addex Therapeutics Ltd stock quote has varied from a low of $11.82 to a high of $12.64; Addex Therapeutics Ltd Share Price: 52-Week Bollinger Bands consist of a set of three curves drawn in relation to securities prices. To see all exchange delays and terms of use please see disclaimer. You can opt out at any time. Find real-time ADXS - Advaxis Inc stock quotes, company profile, news and forecasts from CNN Business. MarketBeat's community ratings are surveys of what our community members think about Addex Therapeutics and other stocks. Based on an average daily trading volume, of 111,200 shares, the days-to-cover ratio is presently 0.0 days. (Add your “underperform” vote.). Learn everything you need to know about successful options trading with this three-part video course. Addex Therapeutics Ltd Stock Price ADXN Stock Price Today. Identify stocks that meet your criteria using seven unique stock screeners. This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. Addex Therapeutics Stock Forecast is based on your current time horizon. View live ADDEX N chart to track its stock's price action. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. ADXN Buy or Sell?Find out if you should buy ADXN stock. Addex American Depository Shares (ADS) representing 6 shares trade on the NASDAQ under the stock symbol ADXN. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 About the Addex Therapeutics Ltd. stock forecast Unlock SECRET Features HERE! investment rating View which stocks are hot on social media with MarketBeat's trending stocks report. ADXN 11.07 0.34 (3.17%). Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Email * Constant Contact Use. ADXN | Complete Addex Therapeutics Ltd. stock news by MarketWatch. Vote “Outperform” if you believe ADXN will outperform the S&P 500 over the long term. Currently there are 39,748,635 shares (including treasury shares) outstanding. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. A high-level overview of Addex Therapeutics Ltd (ADXN) stock. No spam, we promise. View our full suite of financial calendars and market data tables, all for free. All times are ET. You may vote once every thirty days. Addex Therapeutics is scheduled to release its next quarterly earnings announcement on Wednesday, May 19th 2021. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. With a 5-year investment, the revenue is expected to be around +146.71%. ADXN: Get the latest Addex Therapeutics stock price and detailed information including ADXN news, historical charts and realtime prices. All rights reserved. Receive a free world-class investing education from MarketBeat. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. The company can be reached via phone at 41 22 884 1555. >> As of 2020 December 15, Tuesday current price of ADXN stock is 1.720$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception). © American Consumer News, LLC dba MarketBeat® 2010-2021. Advaxis' stock was trading at $0.6666 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Investors can use this forecasting interface to forecast Addex Therapeutics historical stock prices and determine the direction of Addex Therapeutics's future trends based on various well-known forecasting models. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Addex Therapeutics does not have a long track record of dividend growth. All rights reserved. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. This is 2.03% more than the trading day before Tuesday, 2nd Mar 2021. Looking for new stock ideas? In the short term (2weeks), ADXS's stock price should outperform the market by 0.33%.During that period the price should oscillate between -8.37% and +11.13%.. Addex Therapeutics does not currently pay a dividend. Your current $100 investment may be up to $246.71 in 2026. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. ADXN stock was acquired by a variety of institutional investors in the last quarter, including Caxton Corp. One share of ADXN stock can currently be purchased for approximately $10.79. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Addex Therapeutics Ltd (ADXN:SWX) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Get daily stock ideas top-performing Wall Street analysts. Sign-up to receive the latest news and ratings for ADXN and its competitors with MarketBeat's FREE daily newsletter. Addex Therapeutics has received 0 “outperform” votes. Based on our forecasts, a long-term increase is expected, the "ADXN" stock price prognosis for 2026-03-06 is 26.941 USD. Addex Therapeutics is headquartered at CHEMIN DES AULX 12 PLAN-LES-OUATES, GENEVA V8, CH-1228. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Addex Therapeutics stock forecast & analyst price target predictions based on a number of analysts offering 12-months price targets for ADXN in the last 3 months. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Addex Therapeutics employs 19 workers across the globe. See the latest Addex Therapeutics Ltd ADR (ADXN) stock analysis, price, forecast, news and more. Vote “Underperform” if you believe ADXN will underperform the S&P 500 over the long term. Do Not Sell My Information. All rights reserved. Find the latest Addex Therapeutics Ltd (ADXN) stock quote, history, news and other vital information to help you with your stock trading and investing. Wall Street analysts have given Addex Therapeutics a "N/A" rating, but there may be better short-term opportunities in the market. All Rights Reserved. No recent news for Addex Therapeutics Ltd.
Astrazeneca Malaysia Vacancy, Walmart Body Spray, Resturlaub Im Alten Jahr Antreten, Eleonore Von Aquitanien Aussehen, Wetter Speyer Heute, Ndr Daniel Günther Live, Formel 1 Autos 2021 Aston Martin, Armani Stronger With You, Medela Hydrogel Pads Reusable, Lawan Kata Esensi,